PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacy, Northwestern Memorial Hospital, Chicago, IL, USA.\', \'Department of Pharmacy Practice, Midwestern University Chicago College of Pharmacy, Downers Grove, IL, USA.\', \'Pharmacometrics Center of Excellence, Midwestern University Chicago College of Pharmacy, Downers Grove, IL, USA.\', \'Department of Pharmacy Practice, Section of Infectious Diseases Pharmacotherapy, University of Illinois at Chicago, College of Pharmacy, Chicago, IL, USA.\', \'Department of Pharmacy, Northwestern Medicine Delnor Hospital, Geneva, IL, USA.\', \'Department of Pharmacy, Northwestern Medicine Central DuPage Hospital, Winfield, IL, USA.\', \'Department of Pharmacy, University of Utah Health.\', \'Department of Medicine, University of Utah School of Medicine.\', \'Department of Pharmacy, Wake Forest Baptist Health, Winston-Salem, NC, USA.\', \'Wake Forest School of Medicine, Winston-Salem, NC, USA.\', \'Department of Pharmacy, Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA.\', \'Department of Pharmacy, Cleveland Clinic Hospital, Cleveland, OH, USA.\', \'Department of Pharmacy, University of Wisconsin Health, Madison WI, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/ajhp/zxaa426
?:doi
?:hasPublicationType
?:journal
  • American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
is ?:pmid of
?:pmid
?:pmid
  • 33537767
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Multicenter point prevalence evaluation of the utilization and safety of drug therapies for COVID-19 at the onset of the pandemic timeline in the United States.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all